Emergent BioSolutions Inc.
EBS· NYSE
EBSEmergent BioSolutions Inc.
Source filing unavailable
| Metric | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Revenue | $98.11M | $94.61M | $107.95M | — |
| Net Income | $15.22M | $16.10M | $28.66M | — |
| EPS Diluted | $0.41 | $0.44 | $0.78 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Emergent BioSolutions Inc. · CIK 1367644 · Engraved from SEC EDGAR
